Skip to main content
Mylan HIV drug to be sold in India

Mylan's antiretroviral drug Avonza for first-line treatment of HIV/AIDS gained approval for release in India. Mylan says Avonza, recommended by the World Health Organization as an alternative first-line HIV/AIDS treatment, will cost less than other such ARVs.

Full Story: